Theravance Biopharma, Inc. (TBPH) Ownership

$14.41

north_east
$0.34 (2.42%)
Day's range
$14.08
Day's range
$14.44

Theravance Biopharma, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
MADISON AVENUE PARTNERS, LP 11/14/2025 9.51 M $138.86 M   0.00% 18.96%
WEISS ASSET MANAGEMENT LP 11/14/2025 7.46 M $108.87 M   0.00% 14.86%
NEWTYN MANAGEMENT, LLC 11/14/2025 4.95 M $72.27 M   0.00% 9.87%
BLACKROCK, INC. 11/12/2025 4.07 M $59.41 M   -1.69% 8.11%
IRENIC CAPITAL MANAGEMENT LP 11/14/2025 2.76 M $40.31 M   0.00% 5.50%
VANGUARD GROUP INC 11/07/2025 2.21 M $32.29 M   2.51% 4.41%
PARK WEST ASSET MANAGEMENT LLC 11/14/2025 1.28 M $18.75 M   -28.63% 2.56%
D. E. SHAW & CO., INC. 11/14/2025 1.21 M $17.66 M   20.72% 2.41%
OASIS MANAGEMENT CO LTD. 11/14/2025 1.12 M $16.34 M   0.00% 2.23%
ACADIAN ASSET MANAGEMENT LLC 11/13/2025 1.09 M $15.90 M   252.95% 2.17%
STATE STREET CORP 11/14/2025 1.06 M $15.42 M   1.96% 2.10%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 897.99 K $13.11 M   0.45% 1.79%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 766.70 K $11.19 M   6.18% 1.53%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 11/13/2025 726.78 K $10.61 M   100.00% 1.45%
MORGAN STANLEY 11/14/2025 599.55 K $8.75 M   8.89% 1.19%
BANK OF AMERICA CORP /DE/ 11/14/2025 527.11 K $7.70 M   -2.32% 1.05%
UBS GROUP AG 11/13/2025 514.17 K $7.51 M   29.47% 1.02%
ASSENAGON ASSET MANAGEMENT S.A. 10/07/2025 414.72 K $6.05 M   1,629.42% 0.83%
BNP PARIBAS ARBITRAGE, SNC 11/13/2025 373.60 K $5.45 M   -3.58% 0.74%
MARSHALL WACE, LLP 11/13/2025 357.65 K $5.22 M   254.89% 0.71%
NORTHERN TRUST CORP 11/14/2025 341.31 K $4.98 M   -3.10% 0.68%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 320.14 K $4.67 M   5.35% 0.64%
HILLSDALE INVESTMENT MANAGEMENT INC. 11/10/2025 310.70 K $4.54 M   100.00% 0.62%
TANG CAPITAL MANAGEMENT LLC 11/14/2025 264.31 K $3.86 M   0.00% 0.53%
GOLDMAN SACHS GROUP INC 11/14/2025 258.65 K $3.78 M   29.72% 0.52%
TWO SIGMA INVESTMENTS, LP 11/14/2025 231.27 K $3.38 M   1,199.87% 0.46%
JPMORGAN CHASE & CO 11/26/2025 213.10 K $3.11 M   78.31% 0.42%
QUBE RESEARCH & TECHNOLOGIES LTD 11/14/2025 211.05 K $3.08 M   2.81% 0.42%
MACQUARIE GROUP LTD 11/13/2025 208.78 K $3.05 M   0.00% 0.42%
TWO SIGMA ADVISERS, LP 11/14/2025 200.30 K $2.92 M   588.32% 0.40%
ALGERT GLOBAL LLC 11/14/2025 199.71 K $2.92 M   100.00% 0.40%
JANE STREET GROUP, LLC 11/14/2025 191.80 K $2.80 M   348.50% 0.38%
LOS ANGELES CAPITAL MANAGEMENT LLC 10/20/2025 181.48 K $2.65 M   814.24% 0.36%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 11/13/2025 174.84 K $2.55 M   208.83% 0.35%
TREXQUANT INVESTMENT LP 11/14/2025 144.53 K $2.11 M   -7.90% 0.29%
WELLINGTON MANAGEMENT GROUP LLP 11/14/2025 130.15 K $1.90 M   -22.27% 0.26%
JANUS HENDERSON GROUP PLC 11/14/2025 127.21 K $1.86 M   100.00% 0.25%
BARCLAYS PLC 11/12/2025 115.39 K $1.68 M   -12.45% 0.23%
BANK OF NEW YORK MELLON CORP 11/03/2025 114.57 K $1.67 M   3.64% 0.23%
PDT PARTNERS, LLC 11/17/2025 109.71 K $1.60 M   -8.82% 0.22%
JANE STREET GROUP, LLC 11/14/2025 101.10 K $1.48 M   100.00% 0.20%
AMERICAN CENTURY COMPANIES INC 11/12/2025 95.73 K $1.40 M   4.62% 0.19%
FRANKLIN RESOURCES INC 11/13/2025 92.43 K $1.35 M   158.11% 0.18%
NUVEEN, LLC 11/12/2025 92.21 K $1.35 M   -23.53% 0.18%
GSA CAPITAL PARTNERS LLP 11/07/2025 92.18 K $1.35 M   -33.18% 0.18%
MAN GROUP PLC 11/14/2025 79.79 K $1.16 M   100.00% 0.16%
WINTON GROUP LTD 11/13/2025 76.54 K $1.12 M   100.00% 0.15%
INSPIRE INVESTING, LLC 10/15/2025 73.56 K $1.07 M   100.00% 0.15%
MARTINGALE ASSET MANAGEMENT L P 11/13/2025 70.97 K $1.04 M   3.09% 0.14%
ALLIANCEBERNSTEIN L.P. 11/14/2025 70.08 K $1.02 M   0.00% 0.14%

Theravance Biopharma, Inc. institutional Ownership - FAQ's

During the previous two years, 217 institutional investors and hedge funds held shares of Theravance Biopharma, Inc.. The most heavily invested institutionals were:

Madison Avenue Partners, LP: 9.51 M

Weiss Asset Management LP: 7.46 M

Newtyn Management, LLC: 4.95 M

BlackRock, Inc.: 4.07 M

Irenic Capital Management LP: 2.76 M

VANGUARD GROUP INC: 2.21 M

96.43% of Theravance Biopharma, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 76.30 M shares in the last 24 months. This purchase volume represents approximately $1.10 B in transactions.